MODERNA SAYS ITS COVID VACCINE 94.5 % EFFICIENT, WILL SEEK US FDA'S EUA

Highlights

• Days after Pfizer and BioNTech reported over 90 percent efficacy of its COVID-19 vaccine candidate, biotechnology company Moderna announced results of its phase three trials

• Following its announcement, Moderna said it intends to submit the COVID-19 vaccine candidate for an Emergency Use Authorization (EUA) with the United States’ Food & Drug Administration (FDA)

• The report....